The impact of use serum carcinoembryonic antigen and beta 2-microglobulin in monitoring bronchogenic carcinoma therapy (Record no. 41815)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01919cab a2200265Ia 45 0 |
| 001 - CONTROL NUMBER | |
| control field | u186699 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | SIRSI |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 101102s2007 ua ss b eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | EAL |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) | |
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) | ART JGEB V5 No1-2 6 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Ragab, Halla |
| 240 10 - UNIFORM TITLE | |
| Uniform title | Journal of genetic engineering and biotechnology, 2007.v. 5 (1-2) |
| Medium | [electronic resource]. |
| 245 14 - TITLE STATEMENT | |
| Title | The impact of use serum carcinoembryonic antigen and beta 2-microglobulin in monitoring bronchogenic carcinoma therapy |
| Medium | [electronic resource]. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | p.43-50. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc. note | Includes references. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Bronchogenic carcinoma is a disease ofuncontrolled cell growth in tissues ofthe lung. This growth may lead to metastasis. Bronchogenic carcinoma, the most common cause of cancer-related death in men and the second most common in women (after breast cancer), it is responsible for 1.3 million deaths worldwide annually. The aim of this current study is to evaluate the prognostic properties and discriminative values of serum carcinoembryonic antigen (CEA) and beta2microglobulin (β2 M) in different stages of bronchogenic carcinoma. Its feasibility usage an easy and cheap marker especially in developing countries and their use instead an invasive biopsy to avoid its risk factors for improving the accuracy of diagnosing and screening of bronchogenic carcinoma. In addition, we aim to detect and monitor the response to the therapy. This prospective study performed on eighty patients with bronchogenic carcinoma before receiving any treatment. |
| 596 ## - | |
| -- | 1 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lungs |
| General subdivision | Cancer |
| -- | Treatment. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Small cell lung cancer. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Radiography, Medical. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Abd El Maksoud, Nabila |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Essam, Tarek |
| 773 0# - HOST ITEM ENTRY | |
| Title | Journal of genetic engineering and biotechnology. |
| Related parts | 2007.v.5(1-2) |
| International Standard Serial Number | 1687-157X |
| Control subfield | nnas |
| Record control number | u186667 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://nile.enal.sci.eg/EALE/2007/JGEB/507/1/43.pdf">http://nile.enal.sci.eg/EALE/2007/JGEB/507/1/43.pdf</a> |
| Public note | Full Text Article |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Articles |
| Source of classification or shelving scheme | Library of Congress Classification |
No items available.